Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 68, Issue 2, Pages 275-283
Publisher
Oxford University Press (OUP)
Online
2012-10-19
DOI
10.1093/jac/dks405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
- (2012) Kathy Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem-Clavulanic Acid Shows Activity against Mycobacterium tuberculosis In Vivo
- (2012) Kathleen England et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010
- (2012) Matteo Zignol et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Totally Drug-Resistant and Extremely Drug-Resistant Tuberculosis: The Same Disease?
- (2012) G. B. Migliori et al. CLINICAL INFECTIOUS DISEASES
- Fourteen years in resistance
- (2012) David M. Livermore INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study]
- (2012) M. C. Payen et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
- (2012) W.-J. Koh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
- (2012) Christian Lienhardt et al. JOURNAL OF INFECTIOUS DISEASES
- A Major Genome Region Underlying Artemisinin Resistance in Malaria
- (2012) I. H. Cheeseman et al. SCIENCE
- Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies
- (2012) Laurent Poirel et al. Frontiers in Microbiology
- Linezolid, the first oxazolidinone antibacterial agent
- (2011) Karen L. Leach et al. Annals of the New York Academy of Sciences
- Activity of Carbapenems Combined with Clavulanate against Murine Tuberculosis
- (2011) Nicolas Veziris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy
- (2011) Howard Takiff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mefloquine–oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113
- (2011) Raoni S.B. Gonçalves et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Exploiting drug-disease relationships for computational drug repositioning
- (2011) J. T. Dudley et al. BRIEFINGS IN BIOINFORMATICS
- Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
- (2011) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Totally Drug-Resistant Tuberculosis in India
- (2011) Z. F. Udwadia et al. CLINICAL INFECTIOUS DISEASES
- Update on antibacterial and antifungal drugs – can we master the resistance crisis?
- (2011) Ursula Theuretzbacher et al. CURRENT OPINION IN PHARMACOLOGY
- Resistance drives antibacterial drug development
- (2011) Ursula Theuretzbacher CURRENT OPINION IN PHARMACOLOGY
- Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
- (2011) Weon Bin Im et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania
- (2011) J. van den Boogaard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- MRSA: the first half century
- (2011) R. C. Moellering JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan
- (2011) T.-S. Huang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
- (2011) E. Abbate et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clofazimine: current status and future prospects
- (2011) M. C. Cholo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
- (2011) P. E. Almeida Da Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mefloquine neurotoxicity and gap junction blockade: Critical insights in drug repositioning
- (2011) Remington L. Nevin NEUROTOXICOLOGY
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of Mutations in Dihydrofolate Reductase DfrA (Rv2763c) and Thymidylate Synthase ThyA (Rv2764c) in Mycobacterium tuberculosis Drug Resistance
- (2010) C. U. Koser et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium tuberculosis and Sulfamethoxazole Susceptibility
- (2010) W. Ong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium tuberculosis Dihydrofolate Reductase Is Not a Target Relevant to the Antitubercular Activity of Isoniazid
- (2010) F. Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis
- (2010) Karen R. Jacobson et al. CLINICAL INFECTIOUS DISEASES
- Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
- (2010) M. Sester et al. EUROPEAN RESPIRATORY JOURNAL
- Fluoroquinolones in the management of community-acquired pneumonia in primary care
- (2010) Brian Wispelwey et al. Expert Review of Anti-Infective Therapy
- Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers
- (2010) Robert S. Wallis et al. JOURNAL OF INFECTIOUS DISEASES
- Global tuberculosis drug development pipeline: the need and the reality
- (2010) Zhenkun Ma et al. LANCET
- The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
- (2010) Dick van Soolingen et al. PLoS One
- Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis
- (2009) Kathy N. Williams et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates
- (2009) Y. M. Ho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reconsidering Some Approved Antimicrobial Agents for Tuberculosis
- (2009) L. S. Young ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis and Trimethoprim-Sulfamethoxazole
- (2009) P. Forgacs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV
- (2009) Anand A Date et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
- (2009) Ali Akbar Velayati et al. CHEST
- New Anti-Tuberculosis Drugs: Strategies, Sources and New Molecules
- (2009) Juan Palomino et al. CURRENT MEDICINAL CHEMISTRY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
- (2009) J.-E. Hugonnet et al. SCIENCE
- Low hanging fruit in infectious disease drug development
- (2008) Carl N Kraus CURRENT OPINION IN MICROBIOLOGY
- The Peptidoglycan of Stationary-Phase Mycobacterium tuberculosis Predominantly Contains Cross-Links Generated by L,D-Transpeptidation
- (2008) M. Lavollay et al. JOURNAL OF BACTERIOLOGY
- Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections
- (2008) Steven J. Brickner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Extensively drug-resistant tuberculosis
- (2008) Mandeep Jassal et al. LANCET INFECTIOUS DISEASES
- A Multi-Center Randomised Controlled Trial of Gatifloxacin versus Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adults in Vietnam
- (2008) Christiane Dolecek et al. PLoS One
- Mechanism of action of and resistance to quinolones
- (2008) Anna Fàbrega et al. Microbial Biotechnology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now